title: Effects of cryopreservation on in vitro and in vivo long-term function of human islets.
abstract: BACKGROUND
  The possibility of performing transplantation several days after explant seems to be a peculiarity of islet grafts, and the opportunity to cryopreserve human islets may permit an indefinite period for modulating the recipient immune system. The aim of the present study was the evaluation of in vitro and in vivo functional properties of cryopreserved human islets.
  
  
  METHODS
  We used six consecutive human islet preparations not suitable for an immediate transplantation in diabetic patients because the limited islet mass separated. The in vitro function of cryo and fresh islets was studied by determination of insulin and glucagon secretion in response to such classical stimuli as glucose (16.7 mM), glucose (16.7 mM) + 3-isobutyl-1-methylxanthine (0.1 mM), arginine (10 mM), and tolbutamide (100 microM). In vivo islet function was assessed through intravenous glucose tolerance tests performed at 15, 30, 60, and 90 days after transplantation of 1000 hand-picked fresh or cryopreserved islets in nude mice.
  
  
  RESULTS
  Basal secretion of true insulin was significantly higher in cryopreserved islets than in fresh ones. The response of cryopreserved islets to arginine and glucose + isobutyl-1-methylxanthine seemed partially impaired. Proinsulin-like molecule secretion seemed higher in cryopreserved than in fresh islets in response to all secretagogues used, and the difference was statistically significant for arginine. The capacity of human cryopreserved islets to maintain a correct metabolic control in diabetic nude mice was progressively lost in 3 months.
  
  
  CONCLUSIONS
  These findings showed that cryopreservation affects the function of isolated human islets, maintaining in vivo function for a limited period of time.
authors.affiliation: Department of Surgery, Istituto Scientifico San Raffaele, Università degli Studi di Milano, Milan, Italy. piemonti.lorenzo@hsr.it
authors.forename: L
authors.initials: L
authors.lastname: Piemonti
authors.forename: F
authors.initials: F
authors.lastname: Bertuzzi
authors.forename: R
authors.initials: R
authors.lastname: Nano
authors.forename: B E
authors.initials: BE
authors.lastname: Leone
authors.forename: C
authors.initials: C
authors.lastname: Socci
authors.forename: G
authors.initials: G
authors.lastname: Pozza
authors.forename: V
authors.initials: V
authors.lastname: Di Carlo
mesh_terms: D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D001120:Arginine / Q000494:pharmacology; D015925:Cryopreservation; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology / Q000601:surgery; D005934:Glucagon / Q000378:metabolism; D005947:Glucose / Q000494:pharmacology; D005951:Glucose Tolerance Test; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D016381:Islets of Langerhans Transplantation; D008297:Male; D051379:Mice; D008819:Mice, Nude; D012016:Reference Values; D013997:Time Factors; D014183:Transplantation, Heterologous
chemical_list: D007328:Insulin; D005934:Glucagon; D001120:Arginine; D005947:Glucose; D015056:1-Methyl-3-isobutylxanthine